FDA Moves to Eliminate Short-Form Pharma Commercials with Proposed Disclosure Rule
By Campaign US · Campaign US · 2026-07-13

The Food and Drug Administration is pursuing a policy change that would require pharmaceutical companies to include exhaustive side-effect data within their broadcast advertisements. According to Campaign US, this proposal aims to dismantle the long-standing adequate provision ru
The Food and Drug Administration is pursuing a policy change that would require pharmaceutical companies to include exhaustive side-effect data within their broadcast advertisements. According to Campaign US, this proposal aims to dismantle the long-standing adequate provision ru